Download video

Sunvozertinib & EGFR Exon 20 Insertion NSCLC-Leading Developments & Current Questions in Lung Cancer

140 views

Global Resource for Advancing Cancer Education

3 months ago

Sunvozertinib & EGFR Exon 20 Insertion NSCLC-Leading Developments & Current Questions in Lung Cancer

Sunvozertinib & EGFR Exon 20 Insertion NSCLC-Leading Developments & Current Questions in Lung Cancer

Sunvozertinib \& EGFR Exon 20 Insertion NSCLC-Leading Developments \& Current Questions in Lung Cancer
9:15
Sunvozertinib \& EGFR Exon 20 Insertion NSCLC-Leading Developments \& Current Questions in Lung Cancer
by Global Resource for Advancing Cancer Education
WU-KONG1: sunvozertinib in NSCLC with EGFR exon 20 insertion mutations
3:51
WU-KONG1: sunvozertinib in NSCLC with EGFR exon 20 insertion mutations
by VJOncology
Amivantamab mode of action
1:12
Amivantamab mode of action
by Asif Biotech
Assessing the role of sunvozertinib in pretreated NSCLC and in potential first-line usage
0:57
Assessing the role of sunvozertinib in pretreated NSCLC and in potential first-line usage
by VJOncology
FDA Approval to Zegfrovy for Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations
0:57
FDA Approval to Zegfrovy for Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations
by Med-Chemist
ZEGFROVY (sunvozertinib)- lung cancer
3:30
ZEGFROVY (sunvozertinib)- lung cancer
by Pharmacy Talk USA
Management of Non-Small Cell Lung Cancer (NSCLC) with an EGFR Mutation — Karen Reckamp, MD, MS
34:23
Management of Non-Small Cell Lung Cancer (NSCLC) with an EGFR Mutation — Karen Reckamp, MD, MS
by Research To Practice
Case #1: Treating a Patient with EGFR Exon 19 Lung Cancer- 2024 Case-Based Panel Discussions
19:13
Case #1: Treating a Patient with EGFR Exon 19 Lung Cancer- 2024 Case-Based Panel Discussions
by Global Resource for Advancing Cancer Education
Breakthrough mRNA Lung Cancer Vaccine: BioNTech’s BNT116 Trial Explained
8:39
Breakthrough mRNA Lung Cancer Vaccine: BioNTech’s BNT116 Trial Explained
by Lifelong Vitality
REZILIENT1: zipalertinib in pre-treated EGFR exon 20 insertion-mutant NSCLC
2:07
REZILIENT1: zipalertinib in pre-treated EGFR exon 20 insertion-mutant NSCLC
by VJOncology
Treating Non–Small Cell Lung Cancer With an EGFR Exon 20 Insertion
4:47
Treating Non–Small Cell Lung Cancer With an EGFR Exon 20 Insertion
by OncLive
Developments in ADCs for NSCLC
1:59
Developments in ADCs for NSCLC
by VJOncology
WCLC 2023 highlights: FLAURA2 and EGFR exon20-targeting TKIs
2:54
WCLC 2023 highlights: FLAURA2 and EGFR exon20-targeting TKIs
by VJOncology
Is it non small cell or small cell?
0:31
Is it non small cell or small cell?
by Lung Cancer Foundation of America
NSCLC With EGFR Exon 20 Shows Benefit With Mobocertinib Over Chemotherapy
2:03
NSCLC With EGFR Exon 20 Shows Benefit With Mobocertinib Over Chemotherapy
by Targeted Oncology
Breakthroughs in Cancer Trials: NSCLC, Prostate \& More
4:12
Breakthroughs in Cancer Trials: NSCLC, Prostate \& More
by LucidQuest